Article 10 Jan 2024 Acetaminophen MDL: Judge Excludes All Of Plaintiffs' Causation Experts Pursuant To Newly-Amended FRE Rule 702 United States Healthcare
Article 09 Aug 2023 DEA's New Controlled Substance Theft Or Loss Rule Includes A New Deadline And May Require Changes To Corporate Compliance Systems United States Healthcare
Article 20 Jul 2023 Complex Healthcare Litigation Toolkit: The Use Of Plaintiff Fact Sheets And Summary Jury Trials United States Healthcare
Article 19 Jul 2023 Now What: Recent Supreme Court Decision Opens The Door For Expanded Corporate Personal Jurisdiction United States Healthcare
Article 23 May 2023 Public Nuisance Claims: Altria's Vaping Trial Highlights Potential Expansion United States Healthcare
Article 09 Mar 2022 "Objectively Reasonable" Interpretation Defeats FCA Knowledge In 4th Circuit United States Healthcare
Article 06 Apr 2018 Medicaid Drug Rebate Agreements: Changes Require Immediate Action By Pharmaceutical Manufacturers United States Healthcare
Article 07 Mar 2018 DOJ Issues Guidelines For Enforcement Related To Off-Label Promotion United States Consumer
Article 09 Sep 2016 The EpiPen Controversy Signals Intensifying Scrutiny Of Drug Classification Under Medicaid Rebate Program United States Healthcare
Article 07 Jul 2016 Senate Judiciary Introduces CREATES Act To Expedite Access To Affordable Drugs United States Healthcare